121 related articles for article (PubMed ID: 31188017)
1.
Imai A; Mochizuki D; Misawa Y; Nakagawa T; Endo S; Mima M; Yamada S; Kawasaki H; Kanazawa T; Misawa K
DNA Cell Biol; 2019 Jul; 38(7):678-687. PubMed ID: 31188017
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of
Misawa K; Mochizuki D; Imai A; Misawa Y; Endo S; Mima M; Kawasaki H; Carey TE; Kanazawa T
Clin Epigenetics; 2017; 9():64. PubMed ID: 28616099
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
[TBL] [Abstract][Full Text] [Related]
5. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modification of
Misawa K; Misawa Y; Imai A; Mochizuki D; Endo S; Mima M; Ishikawa R; Kawasaki H; Yamatodani T; Kanazawa T
J Cancer; 2018; 9(6):941-949. PubMed ID: 29581773
[TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
Mohanta S; Sekhar Khora S; Suresh A
Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296
[TBL] [Abstract][Full Text] [Related]
10. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
11. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
[TBL] [Abstract][Full Text] [Related]
12.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
13. Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.
Uchida K; Veeramachaneni R; Huey B; Bhattacharya A; Schmidt BL; Albertson DG
BMC Cancer; 2014 May; 14():353. PubMed ID: 24886209
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer.
Misawa K; Kanazawa T; Misawa Y; Imai A; Endo S; Hakamada K; Mineta H
Cancer Biomark; 2011-2012; 10(3-4):135-44. PubMed ID: 22674299
[TBL] [Abstract][Full Text] [Related]
16. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D
Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615
[TBL] [Abstract][Full Text] [Related]
17. Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
Sailer V; Gevensleben H; Dietrich J; Goltz D; Kristiansen G; Bootz F; Dietrich D
PLoS One; 2017; 12(6):e0179412. PubMed ID: 28617833
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
Reddy VR; Annamalai T; Narayanan V; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
